HemoSonics

OverviewSuggest Edit

HemoSonics, LLC is a privately held medical device company founded to develop and bring to market innovative in vitro diagnostics to characterize hemostasis in a variety of clinical settings. These systems employ a patented approach named sonorheometry (SR), which is faster, easier to use, and has a lower cost than competing technologies. Our products combine a flexible test device with targeted disposable test chambers to diagnose specific defects of hemostasis and inform appropriate therapy. This approach makes our system easier to operate and interpret than existing products. Potential clinical applications include trauma, cardiovascular procedures, organ transplantation, orthopedic surgery, neurological surgery, and labor and delivery among others. Sonorheometry was invented by company founders Walker, Viola, and Lawrence while at the University of Virginia. This technology has undergone clinical and laboratory testing supported by a series of academic and business grants from the National Institutes of Health, the Wallace H. Coulter Foundation for Translational Research, the Office of Naval Research, and private investors. Sonorheometry has been demonstrated in a series of peer-reviewed scientific publications and has undergone both laboratory and clinical evaluation. Standalone prototypes are undergoing further clinical and laboratory evaluation. 
TypePrivate
Founded2004
HQCharlottesville, US
Websitehemosonics.com
Culture scoreA+

Latest Updates

Employees (est.) (May 2020)78(+3%)

Key People/Management at HemoSonics

Bob Roda

Bob Roda

President and Chief Executive Officer
Anne Zavertnik

Anne Zavertnik

Vice President, Regulatory Affairs and Quality Systems
Deborah Winegar

Deborah Winegar

Vice President, Clinical Affairs
Francesco Viola

Francesco Viola

Founder and Chief Scientific Officer
David Bryant

David Bryant

Vice President, Operations
Steve Erwine

Steve Erwine

Chief Financial Officer
Show more

HemoSonics Office Locations

HemoSonics has an office in Charlottesville
Charlottesville, US (HQ)
400 Preston Ave
Charlottesville, US
400 Preston Ave #250
Show all (2)

HemoSonics Financials and Metrics

Summary Metrics

Founding Date

2004

HemoSonics total Funding

$17.3 m

HemoSonics latest funding size

$15 m

Time since last funding

3 years ago
HemoSonics's latest funding round in February 2017 was reported to be $15 m. In total, HemoSonics has raised $17.3 m
Show all financial metrics

HemoSonics Online and Social Media Presence

Embed Graph

HemoSonics Company Culture

  • Overall Culture

    A+

    94/100

  • CEO Rating

    A+

    90/100

  • Compensation

    A+

    100/100

Learn more on Comparably

HemoSonics Blogs

HemoSonics Registers CE Mark for its New QStat® Cartridge, Expanding the Use of its Innovative Quantra® Hemostasis System to Trauma Surgery and Liver Transplant Settings

Charlottesville, VA – September 10, 2019 – HemoSonics is excited to announce that its new QStat Cartridge, an extension of its groundbreaking Quantra Hemostasis System, has registered for CE Mark and is now commercially available in Europe and Hong Kong. The utility of the Quantra System, which was …
Show more

HemoSonics Frequently Asked Questions

  • When was HemoSonics founded?

    HemoSonics was founded in 2004.

  • Who are HemoSonics key executives?

    HemoSonics's key executives are Bob Roda, Anne Zavertnik and Deborah Winegar.

  • How many employees does HemoSonics have?

    HemoSonics has 78 employees.

  • Who are HemoSonics competitors?

    Competitors of HemoSonics include Akers Biosciences, SI-BONE and Magnolia Medical Technologies.

  • Where is HemoSonics headquarters?

    HemoSonics headquarters is located at 400 Preston Ave, Charlottesville.

  • Where are HemoSonics offices?

    HemoSonics has an office in Charlottesville.

  • How many offices does HemoSonics have?

    HemoSonics has 2 offices.